Genmab | Marketskapitalisme



Market Capitalization Endring Dato
Agios Pharmaceuticals USD 1.57B 303M 2025-04
Almirall EUR 2B 233.12M 2025-04
Amarin USD 3.85B 3.66B 2025-04
Amgen USD 155.38B 15.41B 2025-04
argenx SE EUR 31.26B 1.59B 2025-04
AstraZeneca GBP 157.7B 4.61B 2025-04
Bayer EUR 20.62B 1.09B 2025-04
BioMarin Pharmaceutical USD 11.34B 1.19B 2025-04
Exelixis USD 10.33B 1000K 2025-04
Fresenius Medical Care EUR 12.25B 734.92M 2025-04
Galapagos EUR 1.48B 277.97M 2025-04
Genmab DKK 82.03B 16.76B 2025-04
GlaxoSmithKline GBP 55.34B 469.7M 2025-04
GN Store Nord DKK 13.68B 6.54B 2025-04
GRIFOLS EUR 3.41B 3.07B 2025-04
Hikma Pharmaceutical GBP 4.18B 241.88M 2025-04
Insmed USD 10.42B 1.96B 2025-04
Lonza CHF 38.65B 136.39M 2025-04
Merck EUR 50.52B 4.57B 2025-04
Novartis CHF 194.25B 18.5B 2024-12
Regeneron Pharmaceuticals USD 60.81B 8.53B 2025-04
Sanofi EUR 118.41B 10.58B 2024-12



Genmab Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.